Search

Your search keyword '"Giancarlo, Agnelli"' showing total 642 results

Search Constraints

Start Over You searched for: Author "Giancarlo, Agnelli" Remove constraint Author: "Giancarlo, Agnelli"
642 results on '"Giancarlo, Agnelli"'

Search Results

1. Use of Oral Anticoagulants in Patients with Atrial Fibrillation: Preliminary Data from the Italian Atrial Fibrillation (ITALY-AF) Registry

2. Prognostic role of different findings at echocardiography in acute pulmonary embolism: a critical review and meta-analysis

3. Cost‐of‐Illness Analysis of Long‐Term Health Care Resource Use and Disease Burden in Patients With Pulmonary Embolism: Insights From the PREFER in VTE Registry

4. Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation: GARFIELD-AF

5. Venous thromboembolism risk, prophylaxis and management in cancer patients with COVID-19: An unmet medical need

6. Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation

8. Renal function and clinical outcome of patients with cancer-associated venous thromboembolism randomized to receive apixaban or dalteparin. Results from the Caravaggio trial

9. Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives

10. 36-month clinical outcomes of patients with venous thromboembolism

11. Efficacy and safety of two heparin regimens for prevention of venous thromboembolism in hospitalized patients with COVID-19: a meta-analysis

12. Prognostic role of different findings at echocardiography in acute pulmonary embolism: a critical review and meta-analysis

13. Diagnosis and Treatment of Deep Vein Thrombosis in the Emergency Department: Results of an Italian Nominal Group Technique Study

14. Stand on the Same Side Against Covid – 19 Clinical Management of Covid-19

15. Updated meta-analysis on prevention of venous thromboembolism in ambulatory cancer patients

16. Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

17. Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study

18. Management of Thrombosis in High-Risk Patients: Focus on Cancer-Associated Thrombosis

19. GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

20. Type 2 Valvular Heart Disease Affects Decision Making for Anticoagulation in Patients with Atrial Fibrillation: The UMBRIA-Fibrillazione Atriale Prospective Study

21. Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation

23. Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction

25. Thromboembolic Complications in Covid-19: From Clinical Scenario to Laboratory Evidence

27. Practical '1-2-3-4-Day' Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study

28. GUIDELINES ON THE DIAGNOSIS AND MANAGEMENT OF ACUTE PULMONARY EMBOLISM

29. 570 FRAILTY AND DISABILITY IN OLDER PATIENTS AND THE EFFECTS OF APIXABAN ON QUALITY OF LIFE AND DEPRESSIVE SYMPTOMS. THE EXPERIENCE OF THE APULEIO STUDY

30. Hemorrhagic Transformation in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Time to Initiation of Oral Anticoagulant Therapy and Outcomes

31. The complexity of patients hospitalized in Internal Medicine wards evaluated by FADOI-COMPLIMED score(s). A hypothetical approach.

32. Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non–Vitamin‐K Oral Anticoagulants (RAF‐NOACs) Study

33. Upper extremities deep vein thrombosis treated with oral direct anticoagulants: A prospective cohort study

34. Complexity of patients with chronic obstructive pulmonary disease hospitalized in internal medicine: a survey by FADOI

36. Direct Oral Anticoagulants in Old and Frail Patients with Atrial Fibrillation: The Advantages of an Anticoagulation Service

37. Cost-effectiveness of direct oral anticoagulants compared to low-molecular-weight-heparins for treatment of cancer associated venous thromboembolism in Spain

38. Effects of concomitant administration of anticancer agents and apixaban or dalteparin on recurrence and bleeding in patients with cancer-associated venous thromboembolism

39. Risk Factors for Intracerebral Hemorrhage in Patients With Atrial Fibrillation on Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention

40. Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation

41. Concomitant Use of Direct Oral Anticoagulants and Antiepileptic Drugs: A Prospective Cohort Study in Patients with Atrial Fibrillation

43. ICH in primary or metastatic brain cancer patients with or without anticoagulant treatment: a systematic review and meta-analysis

44. Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study

45. Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial

47. Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study

48. Timing of initiation of oral anticoagulants in patients with acute ischemic stroke and atrial fibrillation comparing posterior and anterior circulation strokes

49. Treatment of venous thromboembolism in patients with cancer: from clinical trials to real life

50. Safety of catheter ablation of atrial fibrillation in cancer survivors

Catalog

Books, media, physical & digital resources